Vise Technologies Inc. Purchases 96,548 Shares of Pfizer Inc. $PFE
Market Beat·- Vise Technologies Inc. increased its holdings in Pfizer Inc. by 44.4% during the 2nd quarter, purchasing an additional 96,548 shares to own a total of 314,153 shares valued at $7,565,000. - Pfizer reported quarterly earnings of $0.77 per share with revenue reaching $15.03 billion, outperforming analysts' consensus estimates. - The company faces mixed market conditions, including recent clinical pipeline advancements, ongoing legal liabilities, and an average analyst rating of Hold with a target price of $28.28.Wealthfront Advisers LLC Reduces Position in Pfizer Inc. $PFE
Market Beat·- Wealthfront Advisers LLC reduced its holdings in Pfizer Inc. by 18.4% in the second quarter, retaining 672,665 shares valued at $16,198,000. - Pfizer recently reported a quarterly earnings per share of $0.77 and revenue of $15.03 billion, outperforming analysts' consensus estimates. - Institutional investors and analysts continue to monitor Pfizer amid ongoing clinical pipeline updates, dividend declarations, and patent cliff challenges.